In recent years, it has become accepted that immune cells play an active role in atherogenesis. Through various mouse studies, different subsets of lymphocytes have been shown to contribute to the atherosclerotic burden. However, mechanisms for how these cells contribute to atherogenesis or atheroprotection are not clearly understood. Moreover, an emerging concept is that lymphocytes and macrophages must communicate in the artery wall, but how this crosstalk influences atherogenesis is not clearly defined. In this PPG, we will study the immunobiology of atherosclerosis, with the goal of understanding how macrophages and lymphocytes communicate in the aortic wall to odulate atherogenesis. The PPG is comprised of three Projects and two Cores. In Project 1, Dr Hedrick will investigate how T regulatory lymphocyte function is changed during atherogenesis and subjects with Type 2 diabetes. In Project 2, Drs. Miller and Witztum will investigate how oxidized cholesteryl esters modulate TLR signaling in macrophages to influence metabolic endotoxemia and atherogenesis. Project 3 (McNamara) will study how B cells confer atheroprotection, and how the ranscriptional repressor Id3 influences B cell function in the aortic wall. The development of these projects involves extensive collaborations among all investigators. The Projects will be supported by two Cores, an Administrative Core and a Human Phenotyping and Immune Cell Core. This Human Core provides a translational aspect to our Program, providing blood samples, extensive subject phenotyping, and atherosclerosis assessment for subjects with and without Type 2 diabetes. As cardiovascular disease is a major risk factor for subjects with Type 2 diabetes, having access to such samples is a unique translational opportunity for our Program. Each project will utilize the Human Core to study immune cells from human subjects to establish functional links between candidate genes of interest and immune cell function in atherogenesis.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Program Projects (P01)
Project #
2P01HL055798-16A1
Application #
8339636
Study Section
Special Emphasis Panel (ZHL1-CSR-A (M1))
Program Officer
Liu, Lijuan
Project Start
1997-09-08
Project End
2017-07-31
Budget Start
2012-08-01
Budget End
2013-07-31
Support Year
16
Fiscal Year
2012
Total Cost
$2,006,008
Indirect Cost
$342,741
Name
La Jolla Institute
Department
Type
DUNS #
603880287
City
La Jolla
State
CA
Country
United States
Zip Code
92037
Jeong, Se-Jin; Kim, Sinai; Park, Jong-Gil et al. (2018) Prdx1 (peroxiredoxin 1) deficiency reduces cholesterol efflux via impaired macrophage lipophagic flux. Autophagy 14:120-133
Gao, Chuan; Tabb, Keri L; Dimitrov, Latchezar M et al. (2018) Exome Sequencing Identifies Genetic Variants Associated with Circulating Lipid Levels in Mexican Americans: The Insulin Resistance Atherosclerosis Family Study (IRASFS). Sci Rep 8:5603
Gaddis, Dalia E; Padgett, Lindsey E; Wu, Runpei et al. (2018) Apolipoprotein AI prevents regulatory to follicular helper T cell switching during atherosclerosis. Nat Commun 9:1095
Que, Xuchu; Hung, Ming-Yow; Yeang, Calvin et al. (2018) Oxidized phospholipids are proinflammatory and proatherogenic in hypercholesterolaemic mice. Nature 558:301-306
Senders, Max L; Que, Xuchu; Cho, Young Seok et al. (2018) PET/MR Imaging of Malondialdehyde-Acetaldehyde Epitopes With a Human Antibody Detects Clinically Relevant Atherothrombosis. J Am Coll Cardiol 71:321-335
Byun, Young Sup; Yang, Xiaohong; Bao, Weihang et al. (2017) Oxidized Phospholipids on Apolipoprotein B-100 and Recurrent Ischemic Events Following Stroke or Transient Ischemic Attack. J Am Coll Cardiol 69:147-158
Torzewski, Michael; Ravandi, Amir; Yeang, Calvin et al. (2017) Lipoprotein(a) Associated Molecules are Prominent Components in Plasma and Valve Leaflets in Calcific Aortic Valve Stenosis. JACC Basic Transl Sci 2:229-240
Moriarty, Patrick M; Varvel, Stephen A; Gordts, Philip L S M et al. (2017) Lipoprotein(a) Mass Levels Increase Significantly According to APOE Genotype: An Analysis of 431?239 Patients. Arterioscler Thromb Vasc Biol 37:580-588
Yeang, Calvin; Gordts, Philip L S M; Tsimikas, Sotirios (2017) Novel Lipoprotein(a) Catabolism Pathway via Apolipoprotein(a) Recycling: Adding the Plasminogen Receptor PlgRKT to the List. Circ Res 120:1050-1052
Ley, Klaus; Gerdes, Norbert; Winkels, Holger (2017) ATVB Distinguished Scientist Award: How Costimulatory and Coinhibitory Pathways Shape Atherosclerosis. Arterioscler Thromb Vasc Biol 37:764-777

Showing the most recent 10 out of 217 publications